`

Madrigal Pharmaceuticals

Pharmaceutical Manufacturing

Specialities :
Liver disease
Nash
Metabolic disease
And mash
Last Updated: November 20, 2025
Sign Up to View More
Revenue
$180.13M
funding-icon Total Funding
$690.0M
Size
201 - 500
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Madrigal Pharmaceuticals

What does Madrigal pharmaceuticals do?+

Madrigal (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. For more information, visit www.madrigalpharma.com

What are Madrigal pharmaceuticals's specialties? +

Liver disease,nash,metabolic disease,and mash

What is Madrigal pharmaceuticals's industry? +

Madrigal pharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Madrigal pharmaceuticals's revenue? +

Madrigal pharmaceuticals's revenue is $180.13m

What is Madrigal pharmaceuticals's company size? +

Madrigal pharmaceuticals has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free